Skip to main content
OpenTrials

Clinical trial condition

Stage IV Mantle Cell Lymphoma

Explore clinical trials studying Stage IV Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

48 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Mantle Cell Lymphoma trial results

Active, not recruiting

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

NCT02797470

Conditions
Blood-Borne Infections, Burkitt Lymphoma, Communicable Diseases, +41 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma

NCT02242097

Conditions
Contiguous Stage II Mantle Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Northwestern University- Lake Forest Hospital Lake Forest, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

NCT02213913

Conditions
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +104 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • NorthShore University HealthSystem Evanston, Illinois, United States
View Trial Details
Completed

Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT01527149

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details

Related conditions